Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Charles Cox
University of Texas Hlth Sci Ctr Houston, Department: Pediatrics
Should you be removed from our database? Contact us at [email protected]. Read more below.
Cellvation
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
Dr. Cox owns equity, receives compensation for scientific advisory services, and may receive travel reimbursement from Cellvation, which is a subsidiary of Fortress Biotech, Inc., a public, for-profit biopharmaceutical company dedicated to acquiring, developing, and commercializing novel pharmaceutical and biotechnology products. This recently acquired significant financial interest was obtained after the research had already initiated. The research aims to detect the effect of autologous bone marrow mononuclear cells in pediatric patients suffering severe traumatic brain injury. Cellvation has a license agreement from the University of Texas to access and further develop the methodology. The research uses and studies the related methodology.
Phase 2 Pediatric Autologous BMMNC for Severe TBI
The proposed Phase 2 clinical trial will examine the effects of using bone marrow derived cells to treat severe traumatic brain injury in children. The study will test if these cells preserve injured brain tissue after traumatic injury. Preservation of brain tisue is associated with improvement in functional and cognitive outcomes.
Filed on December 19, 2016.
Tell us what you know about Charles Cox's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Charles Cox filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Charles Cox | University of Texas Hlth Sci Ctr Houston | Conflict of Interest | Cellvation, Inc. | $20,000 - $39,999 |
| Charles Cox | University of Texas Hlth Sci Ctr Houston | Conflict of Interest | Cellvation | $20,000 - $39,999 |
| Charles Cox | University of Texas Hlth Sci Ctr Houston | Conflict of Interest | Cellvation | $0 - $4,999 |
| Charles Cox | University of Texas Hlth Sci Ctr Houston | Conflict of Interest | Cellvation, Inc. | $0 - $4,999 |
| Charles Cox | University of Texas Hlth Sci Ctr Houston | Conflict of Interest | Cellvation, Inc. | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.